The aim of the present study was to examine the efficacy of a probiotic-based product on either reducing hypertension or preventing a high normal blood pressure from reaching hypertensive levels.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
142
Unnamed facility
Malmo, Sweden
Changes from baseline in systolic and diastolic blood pressure after 3 months of probiotic intervention
Time frame: Baseline, 3 months
Changes from baseline of blood parameters, such as inflammatory markers and blood lipids, linked to increased risk for cardiovascular diseases
Time frame: Baseline, 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.